Skip to main content Skip to section navigation Skip to footer
Careers News & Media Contact
OPKO Health, Inc. OPKO Health, Inc.
  • Therapies
    • Overview
    • Ngenla
    • Rayaldee
  • Research
    • Overview
    • Pipeline
    • Publications
    • Scientific Presentations
  • Diagnostics
  • Company
    • Overview
    • Leadership
    • Locations
  • Partnerships
  • Investors
    • Overview
    • News / Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • News & Media
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations
Feb 01, 2017 8:30am EST

OPKO’S GeneDx Announces Research Collaboration with the Wellcome Trust Sanger Institute

Jan 10, 2017 8:30am EST

OPKO Investee Zebra Biologics Announces Collaboration with AbbVie to Discover New Antibody Therapeutics

Jan 09, 2017 1:31pm EST

OPKO Announces Initiation of Claros® 1 Clinical Trial for Total PSA

Jan 04, 2017 8:30am EST

OPKO Health to Present at the J.P. Morgan 35th Annual Healthcare Conference

Dec 30, 2016 8:25am EST

OPKO Health Provides Update on hGH-CTP Clinical Programs

Dec 19, 2016 9:00am EST

OPKO Health to be Added to the NASDAQ Biotechnology Index

Nov 30, 2016 8:00am EST

OPKO Health to Participate at Three Investment Conferences in December

Nov 23, 2016 11:31am EST

OPKO Announces U.S. Launch of RAYALDEE™

Nov 17, 2016 8:30am EST

OPKO Presents Data on RAYALDEE® at ASN Kidney Week 2016

Nov 07, 2016 4:22pm EST

OPKO Health Reports Third Quarter Financial and Operating Results

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • …
  • Page 52
  • Next Pagearrow_forward
rss_feed News RSS

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137


T: 305-575-4100
contact@opko.com

©2025 OPKO Health, Inc. All Rights Reserved.
Privacy Policy Governance Terms of use Sitemap